CD4 and melanoma: The whole-cell vaccine optimized by CpG/αOX40/cGAMP can fully mobilize the immune system and increase the infiltration of lymphocytes (especially CD4+ T cells) within the tumor, thus significantly preventing the growth of melanoma and prolonging the survival time of melanoma mice.